Making a difference in neuroscience

Nervous system diseases are a major public health challenge and, combined, one of the largest causes of disability worldwide. Ahmed Elhusseiny, Therapy Area Head Neuroscience and Rare Diseases and Paulo Fontoura, Global Head Clinical Development, Neuroscience share their insights on developing medicines with the potential to transform people’s lives. How is Roche approaching neuroscience research and development? Ahmed Elhusseiny (AE): Neuroscience is a challenging area for drug development, but we learn more with each study. We are gaining a better understanding of the underlying biology of nervous system disorders. At Roche, we are focused on four important areas in neuroscience: diseases that cause progressive nerve damage (neurodegeneration); diseases that cause abnormal development of the nervous system (neurodevelopment); psychiatric disorders; and pain. Key diseases include multiple sclerosis (MS), Alzheimer’s disease, Parkinson’s…

Link to Full Article: Making a difference in neuroscience

Pin It on Pinterest

Share This

Join Our Newsletter

Sign up to our mailing list to receive the latest news and updates about and the Informed.AI Network of AI related websites which includes Events.AI, Neurons.AI, Awards.AI, and Vocation.AI

You have Successfully Subscribed!